ICON PLC

2,959.64
USD
(+1.82%)
04/23/2025 - 10:10
Open 15 min delayed data - NASDAQ Stocks
Open: | 2,950.19 |
Change: | +52.75 |
Volume: | 0 |
Low: | 2,944.82 |
High: | 2,965.40 |
High / Low range: | 20.58 |
Type: | Stocks |
Ticker: | ICLR |
ISIN: | IE0005711209 |
ICON PLC news, videos and press releases
For more news please use our advanced search feature.
ICON PLC - More news...
ICON PLC - More news...
- 03/31/2025 - 10:30 ICON plc Schedules First Quarter 2025 Earnings Conference Call
- 03/05/2025 - 12:30 ICON plc to Present at Upcoming Investor Conferences
- 02/19/2025 - 21:15 ICON Reports Fourth Quarter and Full Year 2024 Results
- 01/30/2025 - 12:50 ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies
- 01/29/2025 - 12:15 ICON plc Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call
- 01/14/2025 - 13:00 ICON Issues Financial Guidance for Full Year 2025
- 01/08/2025 - 12:00 Biomarker and Trial Optimisation Needed to Drive R&D Progress in Alzheimer’s and Related Disorders – ICON Survey
- 01/07/2025 - 11:00 ICON plc to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- 12/23/2024 - 12:15 ICON and Its Employees Celebrated for Excellence in the Field of Clinical Research
- 12/18/2024 - 12:00 ICON Announces Appointment of Chief Operating Officer
- 12/05/2024 - 12:15 ICON Survey Highlights Sustained Investment in AI and Digital R&D Innovation, Tempered by Siloed Adoption
- 11/13/2024 - 13:00 ICON plc to Present at the Jefferies London Healthcare Conference
- 07/26/2023 - 20:20 ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting
- 07/26/2023 - 20:15 ICON Reports Second Quarter 2023 Results
- 07/13/2023 - 11:15 First Half of 2023 Sees ICON Recognised for CRO Excellence, Alongside Industry Awards as an Employer of Choice and for Its Creative and Digital Services
- 06/27/2023 - 20:15 ICON plc Schedules Second Quarter 2023 Earnings Conference Call
- 06/26/2023 - 11:15 ICON Releases Latest Version of its Digital Platform, Providing Integrated Patient Services and Harmonised Data in One Platform
- 06/26/2023 - 10:00 ICON plc Set to Join Russell 3000® Index
- 05/31/2023 - 10:00 ICON plc to Attend Upcoming Investor Conferences
- 05/16/2023 - 10:00 ICON releases its 2022 ICON Cares ESG Report
- 04/26/2023 - 20:32 ICON Reports First Quarter 2023 Results
- 03/29/2023 - 10:00 ICON plc Schedules First Quarter 2023 Earnings Conference Call
- 03/10/2023 - 07:00 LEO Pharma and ICON Enter a Strategic Partnership to Propel Clinical Trial Execution Within Medical Dermatology
- 02/27/2023 - 21:15 ICON plc to Present at Upcoming Investor Conferences
- 02/22/2023 - 21:30 ICON Reports Fourth Quarter and Full Year 2022 Results
- 01/26/2023 - 21:15 ICON plc Schedules Fourth Quarter 2022 Earnings Conference Call
- 01/10/2023 - 13:45 ICON Issues Financial Guidance for Full Year 2023
- 01/03/2023 - 21:15 ICON plc to Present at the 41st Annual J.P. Morgan Healthcare Conference
- 12/13/2022 - 12:00 ICON recognised as leading contract research organisation and employer by Scrip, Fierce Life Sciences, Financial Times and others
- 11/23/2022 - 21:15 ICON plc to Present at the 2022 Evercore ISI HealthCONx Conference